Chi Sheng Pharma & Biotech Co., Ltd

TPEX:4111 Stock Report

Market Cap: NT$1.5b

Chi Sheng Pharma & Biotech Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of 4111?
Owner TypeNumber of SharesOwnership Percentage
Institutions1,081,7461.9%
General Public55,901,23998.1%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 1 shareholders own 1.9% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
1.9%
Su Kun Po Medical Research Foundation, Endowment Arm
1,081,746NT$29.0m0%no data